
Delivering nutrients intravenously bypasses digestion entirely and achieves close to complete bioavailability. That is real pharmacology. It is also unnecessary for most healthy people with a working gut, and we will tell you which category you are in.
When you swallow a nutrient it has to survive stomach acid, cross the intestinal wall, and pass through the liver before it reaches circulation. How much arrives varies by nutrient, by dose, and by the person. For some, absorption is the limiting factor rather than intake.
Intravenous delivery skips all of that. The nutrient enters circulation directly, at close to complete bioavailability, at concentrations oral dosing cannot reach. That is a genuine pharmacological difference, and it matters most when absorption or concentration is the actual problem.

Evaluation before anything is prescribed
Most IV clinics run this in the opposite order. You choose a bag from a board, someone places a line, and nobody establishes whether you needed it. We do it the other way around, and that changes what the service actually is.
Documented deficiency, impaired absorption, a clinical situation where oral intake is insufficient, or recovery from something specific. Without one of those, intravenous delivery is a more invasive route to the same result.
Kidney and cardiac function, current medications, and history are reviewed before anything is prescribed. High dose intravenous nutrients are not benign, and some carry real considerations including renal load and vein irritation.
Sterile preparation, clinical staff, and monitoring throughout. Intravenous access carries infection and infiltration risk regardless of what is in the bag, which is why the setting matters as much as the contents.
If we treated a documented deficiency, we retest to confirm it corrected. Repletion has an endpoint. Indefinite weekly infusions with no measured target is not a protocol, it is a subscription.
IV nutrient therapy has become one of the most marketed services in wellness and one of the least evenly evidenced. Both parts are worth stating.
Nutrients delivered intravenously reach systemic circulation without passing through digestion, achieving virtually complete bioavailability. This is established pharmacology, not a marketing claim, and it is the entire legitimate basis for the route.
Peer reviewed reviews support intravenous delivery in defined clinical scenarios: documented deficiency, malabsorption disorders, dehydration, and recovery from surgery or illness. Evidence for use in generally healthy people seeking a wellness effect is limited, and we will not pretend otherwise.
The FDA has not approved intravenous vitamin therapies for general wellness indications. Claims about immunity, energy, detoxification, or hangover relief circulate widely in this industry and are not supported by that standard of evidence. We do not make them.
Being direct about this saves you a consultation fee and saves us a conversation neither of us needs.
People with a documented deficiency that oral supplementation has not corrected
Those with malabsorption, a relevant gut condition, or a history of bariatric surgery
Recovery from illness, surgery, or a period where intake has genuinely been inadequate
Anyone who wants the evidence explained plainly rather than a wellness pitch
Not for healthy people with a working gut, where oral will do the same job
Not appropriate with certain kidney or cardiac conditions, or during pregnancy
A clinical process with an evaluation at the front and an endpoint at the back.

Monitored throughout, with the rate adjusted to tolerance
We describe what we do rather than what any infusion will achieve, because the second depends entirely on whether the first was warranted.
A physician evaluation determining whether intravenous delivery is warranted at all
Review of labs, absorption history, medications, and relevant organ function
Formulation built from findings rather than selected from a menu
Preparation and administration under sterile clinical conditions
Monitoring throughout the infusion, with rate adjusted to tolerance
Rechecking of markers to confirm whether the deficiency corrected
Transition to oral maintenance where it will hold the result
A clear recommendation against, where that is the honest answer
IV therapy does not sit inside a Circuit. It runs alongside your protocol as a clinical service, and unlike most things here it is meant to end.
Diagnostics come before any clinical conversation. Without a documented finding there is nothing to correct, and correcting nothing is what most of this industry sells.
Where oral supplementation, dietary change, or addressing an absorption issue would achieve the same result, that is what we recommend. Intravenous is the answer when the simpler route has failed or cannot work.
Markers are rechecked, the deficiency is confirmed corrected, and the course ends. Where maintenance is needed we move you to the least invasive route that holds it.
The route is genuinely different. Where that difference translates into benefit is narrower than the industry suggests, and these are the papers that set out both.
Nutrients administered intravenously have virtually complete bioavailability, entering systemic circulation without being subjected to digestive processes. That advantage is real, and it matters most when absorption is the actual problem.
Read those papers and you will find a consistent picture. Intravenous delivery achieves what it claims pharmacologically, and the clinical evidence supports it in targeted scenarios rather than as a general wellness intervention. That is why this page has no drip menu and no list of packages. If your evaluation shows a reason, we will treat it and then stop. If it does not, we will tell you, and you will have saved money.
We do not run a drip menu. What is prescribed depends on what your evaluation finds, and building formulations from findings rather than from packages is the difference between this being a clinical service and a retail one.
We will not phrase it that way. Correcting a genuine deficiency in a nutrient your immune system depends on is a real thing. Infusing nutrients you are not short of, in the hope of boosting a system that is already working, is not, and the evidence does not support it.
No. That is a common offering in this industry and it is not one of ours. Fluids help dehydration, which you can achieve by drinking water, and none of it requires a physician or a cannula.
A fair challenge and often true. If you are already replete, your kidneys will clear the excess of water soluble nutrients, and you will have paid for the privilege. If you are genuinely deficient and not absorbing orally, that is a different situation entirely. Establishing which one applies is the point of the evaluation.
In almost all cases yes. Without a documented finding there is nothing to correct and no way to know whether it worked. If you have recent labs, bring them and we will use them rather than repeating work.
When properly indicated, prepared, and administered, it is well tolerated. It is not risk free. Intravenous access carries infection and infiltration risk, and high dose nutrients can place load on the kidneys or irritate the vein. Screening and sterile technique are how those risks are managed.
As few times as it takes to correct what we found. Repletion has an endpoint, and once markers confirm correction we move you to the simplest route that maintains it. Ongoing indefinite infusions without a measured target is not something we offer.
Generally not, as most of this is elective. Some diagnostics may be eligible for HSA or FSA reimbursement, and we can provide documentation for submission.
No. IV therapy is a clinical service with its own evaluation and its own endpoint. It sits alongside membership rather than inside a Circuit.
Almost everyone asking about IV therapy should begin somewhere else. These are the steps that make this conversation useful.
Diagnostics that establish whether a deficiency exists, so any clinical decision has something to work from.
A twelve week programme where clinical evaluation and the facility modalities run as a single plan.
Sixteen modalities addressing recovery, capacity, and cellular energy without a prescription.
This begins with an evaluation rather than an infusion. In it we will: